Provided is an antibody binding to a TM4SF20 protein. The results demonstrated that the anti-TM4SF20 antibody has ADCC activity, which can be used in the diagnosis and treatment of cancer.
Figure 1 Results of evaluating the binding of the anti-TM4SF20 antibody to a lung adenocarcinoma cell line A549 by flow cytometry.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For research use only. Not intended for any clinical use.